Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Viral Infections, Non-HIV

Household Transmission of SARS-CoV-2

J Infect.

Wang Z, Ma W, Zheng X, Wu G, Zhang R

doi: 10.1016/j.jinf.2020.03.040.

Viral Infections, Non-HIV

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

N Engl J Med.

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ

doi: 10.1056/NEJMc2004973.

Viral Infections, Non-HIV

Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing

doi: 10.4414/smw.2020.20257.

Viral Infections, Non-HIV

Clinical Implications of SARS-CoV-2 Infection in the Viable Preterm Period

Am J Perinatol.

Gulersen M, Blitz MJ, Rochelson B, Nimaroff M, Shan W, Bornstein E

doi: 10.1055/s-0040-1713851.

Viral Infections, Non-HIV

Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2

J Clin Virol.

Egloff C, Vauloup-Fellous C, Picone O, Mandelbrot L, Roques P

doi: 10.1016/j.jcv.2020.104447.

Viral Infections, Non-HIV

Vertical transmission of SARS CoV-2: a systematic review

J Matern Fetal Neonatal Med.

Deniz M, Tezer H

doi: 10.1080/14767058.2020.1793322.

Viral Infections, Non-HIV

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

N Engl J Med.

Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin HP, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA

doi: 10.1056/NEJMoa2008457.

Viral Infections, Non-HIV

Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up

Pathog Dis.

Liu F, Cai ZB, Huang JS, Yu WY, Niu HY, Zhang Y, Sui DM, Wang F, Xue LZ, Xu AF

doi: 10.1093/femspd/ftaa031.

Viral Infections, Non-HIV

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clin Infect Dis.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D

doi: 10.1093/cid/ciaa237.

Related content

Household Transmission of SARS-CoV-2

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing

Clinical Implications of SARS-CoV-2 Infection in the Viable Preterm Period

Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2

Vertical transmission of SARS CoV-2: a systematic review

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)